Clinical trials
Full profile accessFollow clinical development from trial design and recruitment through results.
- Trial phase
- Status
- Readouts
Company intelligence / Profile preview
Heka Pharma is a Berlin-based pharmaceutical company specializing in the medical cannabis sector. Founded in 2019 by industry veterans, the company focuses on the production, distribution, and wholesale of high-quality medical cannabis products, including dried flowers and cannabinoid-based extracts. Heka Pharma operates under strict EU-GMP (Good Manufacturing Practice) standards, ensuring a reliable and high-quality supply chain for pharmacies and healthcare providers across Germany and the European Union. The company aims to bridge the gap between global cultivators and the growing European patient base, providing therapeutic options for conditions such as chronic pain, multiple sclerosis, and chemotherapy-induced nausea.
Beyond the preview
Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.
Follow clinical development from trial design and recruitment through results.
Explore licensing agreements, acquisitions, and the assets behind each deal.
Trace financing activity and the investors behind a company’s development.
Compare peer pipelines by target, modality, and therapeutic area.
Explore technology platforms and the patent landscape around relevant assets.
Connect company news and source material to the questions you’re investigating.
See how Gosset can support your research on HEKAPHARMA.